Chlorogenic Acid and Rutin Play a Major Role in the In Vivo Anti-Diabetic Activity of Morus alba Leaf Extract on Type II Diabetic Rats

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Hunyadi, Attila ^a,b   Martins, Ana ^a,c   Hsieh, Tusty Jiuan ^d   Seres, Adrienn ^e   Zupkó, István ^e  

^a UNIVERSITY OF SZEGED   (Hungary)

^b EUROPEAN COMMISSION   (Belgium)

^c INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROGENIC ACID; GLUCOSE; ISOQUERCITRIN; MULBERRY EXTRACT; RUTOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG DOSE COMPARISON; DRUG ISOLATION; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; QUANTITATIVE ANALYSIS; RAT; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AGENTS; BLOOD GLUCOSE; CHLOROGENIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; MORUS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; QUERCETIN; RATS; RUTIN;

MORUS (ANGIOSPERM); MORUS ALBA; MORUS(ANGIOSPERM); RATTUS;

EID: 84869809410     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050619     Document Type: Article

References (31)

1. Wild SH, Roglic G, Green A, Sicree R, King H, (2004) Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
2. Shaw JE, Sicree RA, Zimmet PZ, (2009) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pr 87: 4-14.
3. Quaseem A, Humphrey L, Shekelle P, (2012) Oral Pharmacological Treatment of Type 2 Diabetes Mellitus. Ann Intern Med 157(1): 76-77.
4. Hikino H, Mizuno T, Oshima Y, Konno C, (1985) Isolation and hypoglycemic activity of Moran A, a glycoprotein of Morus alba root barks. Planta Med 2: 159-160.
5. Chen F, Nakashima N, Kimura I, Kimura M, (1995) Hypoglycemic activity and mechanisms of extracts from mulberry leaves (folium mori) and cortex mori radicis in streptozotocin-induced diabetic mice. Yakugaku Zasshi 115: 476-482.
6. Taniguchi S, Asano N, Tomino F, Miwa I, (1998) Potentiation of glucose-induced insuline secretion by fagomine, a pseudo-sugar isolated from mulberry leaves. Horm Metab Res 30: 679-683.
7. Kim ES, Park SJ, Lee EJ, Kim BK, Huh H, et al. (1999) Purification and characterization of Moran 20K from Morus alba. Arch Pharm Res 22: 9-12.
8. Lemus I, García R, Delvillar E, Knop G, (1999) Hypoglycaemic activity of four plants used in Chilean popular medicine. Phytother Res 13: 91-94.
9. Miyahara C, Miyazawa M, Satoh S, Sakai A, Mizusaki S, (2004) Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J Nutr Sci Vitaminol 50: 161-164.
10. Andallu B, Suryakantham V, Lakshmi SB, Reddy GK, (2001) Effect of mulberry (Morus alba L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes. Clin Chim Acta 314: 47-53.
11. Murata K, Yatsunami K, Mizukami O, Toriumi Y, Hoshino G, et al. (2003) Effects of propolis and mulberry leaf extract on type 2 diabetes. Focus Alternat Complement Ther 8: 4524-4525.
12. Mudra M, Ercan-Fang N, Zhong L, Furne J, Levitt M, (2007) Influence of mulberry leaf extract on the blood glucose and breath hydrogen response to ingestion of 75 g sucrose by type 2 diabetic and control subjects. Diabetes Care 30: 1272-1274.
13. Kimura T, Nakagawa K, Kubota H, Kojima Y, Goto Y, et al. (2007) Food-Grade Mulberry Powder Enriched with 1-Deoxynojirimycin Suppresses the Elevation of Postprandial Blood Glucose in Humans. J Agric Food Chem 55: 5869-5874.
14. Yagi M, Kouno T, Aoyagi Y, Murai H, (1976) Structure of moranoline, a piperidine alkaloid from Morus species. J Agric Chem Soc Japan 50(11): 571-572.
15. Asano N, Oseki K, Tomioka E, Kizu H, Matsui K, (1994) N-containing sugars from Morus alba and their glycosidase inhibitory activities. Carbohydr Res 17: 243-255.
16. Asano N, Yamashita T, Yasuda K, Ikeda K, Kizu H, et al. (2001) Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J Agric Food Chem 49: 4208-4213.
17. Singab AN, El-Beshbishy HA, Yonekawa M, Nomura T, Fukai T, (2005) Hypoglycemic effect of Egyptian Morus alba root bark extract: Effect in diabetes and lipid peroxidation of streptozocin-induced diabetic rats. J Ethnopharmacol 100: 333-338.
18. Basnet P, Kadota S, Terashima S, Shimizu M, Namba T, (1993) Two new arylbenzofuran derivatives from hypoglycemic activity-bearing fractions of Morus insignis. Chem Pharm Bull (Tokyo) 41(7): 1238-43.
19. Qingyi M, Guoqing S, Chuntao C, Jia S, Xiaoyan C, (2006) Studies on inhibitor effects and activator of a-glucosidase in mulberry leaves. Shipin Kexue (Beijing, China) 27(2): 108-111. Chem Abstr 2007: 515791 (article in Chinese).
20. Hunyadi A, Veres K, Danko B, Kele Z, Weber E, et al. (2012) In vitro anti-diabetic activity and chemical composition of an apolar fraction of Morus alba leaf watextract. Phytother Res DOI: 10.1002/ptr.4803.
21. Takemoto T, Ogawa S, Nishimoto N, Hirayama H, Taniguchi S, (1967) Isolation of the insect-moulting hormones from mulberry leaves. Yakugaku Zasshi 87: 748 (article in Japanese).
22. Lafont R, Dinan L (2003) Practical uses for ecdysteroids in mammals including humans: an update. J Insect Sci 3:7; online: http://insectscience.org/3.7.
23. Amézqueta S, Galán E, Fuguet E, Carrascal M, Abián J, et al. (2012) Determination of D-fagomine in buckwheat and mulberry by cation exchange HPLC/ESI-Q-MS. Anal Bioanal Chem 402(5): 1953-1960.
24. Vichasilpa C, Nakagawab K, Sookwongb P, Higuchic O, Luemunkongd S, et al. (2012) Development of high1-deoxynojirimycin (DNJ) contentmulberrytea and use of response surface methodology to optimize tea-making conditions for highest DNJ extraction. LWT-Food Sci Technol 45(2): 226-232.
25. Hunyadi A, Liktor-Busa E, Balogh Á, Hsieh TJ, Zupkó I, et al. (2010) Investigation of the antidiabetic activity of Morus alba leaf extract in vitro and in vivo. Planta Med 76(12): 1217.
26. Andrade-Cetto A, Wiedenfeld H, (2001) Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. J Ethnopharmacol 78: 145-149.
27. Kamalakkannan N, Prince PS, (2006) Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin Pharmacol Toxicol 98(1): 97-103.
28. Spiegl G, Zupkó I, Minorics R, Csík G, Csonka D, et al. (2009) Effects of experimentally induced diabetes mellitus on pharmacologically and electrically elicited myometrial contractility. Clin Exp Pharmacol Physiol 36: 884-891.
29. Portha B, Levacher C, Picon L, Rosselin G, (1974) Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes 23: 889-895.
30. Vogel HG ed. (2002) Drug Discovery and Evaluation. Pharmacological Assays. Springer Verlag: Berlin.
31. Szkudelski T, (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 537-546.